IHS Chemical Week

EnviroTech :: Regulatory :: Regulatory: Legal

FDA Approved 35 New Innovative Drugs in Fiscal 2011

4:21 AM MDT | November 4, 2011 | Deepti Ramesh

The U.S. Food and Drug Administration (FDA) says it approved 35 new medicines in the fiscal year ended September 30, 2011. This is among the highest number of approvals in the past decade, surpassed only by 2009, when 37 drugs were approved. The FDA provided details of the drug approvals in a report released this week. The approved drugs include two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years. Seven of the new medicines are major...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa